Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Alberto Biggi"'
Autor:
Andrea Gallamini, Sally F. Barrington, Alberto Biggi, Stephane Chauvie, Lale Kostakoglu, Michele Gregianin, Michel Meignan, George N. Mikhaeel, Annika Loft, Jan M. Zaucha, John F. Seymour, Michael S. Hofman, Luigi Rigacci, Alessandro Pulsoni, Morton Coleman, Eldad J. Dann, Livio Trentin, Olivier Casasnovas, Chiara Rusconi, Pauline Brice, Silvia Bolis, Simonetta Viviani, Flavia Salvi, Stefano Luminari, Martin Hutchings
Publikováno v:
Haematologica, Vol 99, Iss 6 (2014)
A retrospective, international, multicenter study was undertaken to assess: (i) the prognostic role of ‘interim’ positron emission tomography performed during treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in patients with Hod
Externí odkaz:
https://doaj.org/article/0e9903afcd5841b2a3d617a8a512f95d
Autor:
Alberto Biggi, Stephane Chauvie, Federico Fallanca, Luca Guerra, Fabrizio Bergesio, Massimo Menga, Andrea Bianchi, Michele Gregianin, Agostino Chiaravalloti, Orazio Schillaci, Chiara Pavoni, Caterina Patti, Marco Picardi, Alessandra Romano, Corrado Schiavotto, Roberto Sorasio, Simonetta Viviani, Giorgio La Nasa, Livio Trentin, Alessandro Rambaldi, Andrea Gallamini
The Lugano classification for response assessment in lymphoma recommends the use of the 5-point-scale Deauville Score (DS) to assess response evaluation of end-of-treatment FDG-PET/CT (eotPET) in Hodgkin Lymphoma (HL); nevertheless, there is a paucit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67e7b2e77e3caf37725e131a31053f3a
https://hdl.handle.net/10281/402816
https://hdl.handle.net/10281/402816
Autor:
Federico Fallanca, Andrea Bianchi, Fabrizio Bergesio, Andrea Gallamini, Michele Gregianin, Stephane Chauvie, Michel Meignan, Martin Hutchings, Alberto Biggi, Massimo Menga
Publikováno v:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 65
BACKGROUND Qualitative assessment using the Deauville five-point scale (DS) is the gold standard for interim and end-of treatment PET interpretation in lymphoma. In the present study we assessed the reliability and the prognostic value of different s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5140ed69fa31b04fbaf24f82bdcd2432
https://doi.org/10.23736/s1824-4785.17.02993-4
https://doi.org/10.23736/s1824-4785.17.02993-4
Publikováno v:
Leukemia & Lymphoma. 60:302-308
The Deauville criteria (DC) shall always be used to report interim and final PET and to assign metabolic response categories in FDG-avid lymphoma. A recent review article supports the role of quantitative extension of the DC to improve response asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67578fb807689617ecf85e2ab921a297
https://doi.org/10.1080/10428194.2018.1480773
https://doi.org/10.1080/10428194.2018.1480773
Autor:
Piera Viero, Simonetta Viviani, Giorgio La Nasa, A. Romano, D. Gottardi, Andrés J.M. Ferreri, Paolo Corradini, Livio Trentin, Alberto Biggi, Federico Fallanca, Maria Cantonetti, G. Gini, Atto Billio, Agostino Chiaravalloti, Giuseppe Prosperini, Davide Rapezzi, A. Mulè, Silvia Bolis, R. Zanotti, Marco Picardi, Chiara Pavoni, Guido Parvis, Corrado Tarella, Paolo Gavarotti, Alessandro Massimo Gianni, Maurizio Miglino, Fabrizio Bergesio, Alessandro Rambaldi, S. Chauvie, Abraham Avigdor, Roberta Battistini, Andrea Gallamini, Michele Gregianin, Andrea Rossi, Corrado Schiavotto, Umberto Ficola, Michele Cimminiello, C. Patti
Purpose To investigate the progression-free survival (PFS) of patients with advanced Hodgkin lymphoma (HL) after a risk-adapted treatment strategy that was based on a positive positron emission tomography scan performed after two doxorubicin, vinblas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d931ddc70a8cbce523dd881be6afda2b
https://hdl.handle.net/20.500.11769/542310
https://hdl.handle.net/20.500.11769/542310
Publikováno v:
Clinical Applications of Nuclear Medicine Targeted Therapy ISBN: 9783319630663
Radioimmunotherapy (RIT) using radionuclide labeled anti-CD20 monoclonal antibodies allows for the delivery of the radionuclides directly to the surface of targeted B-cell non-Hodgkin’s lymphoma (NHL) achieving additional cytotoxic effect.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd7dbc1186c273e3570e305d0e11d2ee
https://doi.org/10.1007/978-3-319-63067-0_31
https://doi.org/10.1007/978-3-319-63067-0_31
Publikováno v:
Clinical and Translational Imaging. 3:253-269
Staging defines disease location and extent, suggests prognostic information and provides a baseline against which response or disease progression can be compared. Studies in Hodgkin (HL) and non-Hodgkin lymphoma (NHL) generally conclude that PET/CT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf85072f26807650200eab929fb48c68
https://doi.org/10.1007/s40336-015-0127-x
https://doi.org/10.1007/s40336-015-0127-x
Autor:
Michele Spina, Pier Luigi Zinzani, Francesco Merli, Stefani Piero Maria, Andrea Gallamini, Vittorio Stefoni, Alberto Biggi, Alessandro Levis, Sancetta Rosaria, Luigi Rigacci, Umberto Vitolo, Benedetta Puccini, Alberto Bosi, Antonio Castagnoli, Manuel Gotti, Monica Balzarotti, Caterina Stelitano
Publikováno v:
American Journal of Hematology. 90:499-503
This retrospective study included 246 patients with a new diagnosis of Hodgkin Lymphoma (HL) with a localized-stage (IA-IIA), consecutively admitted from January 2002 to December 2008, by twelve Italian hematological centers on behalf of Fondazione I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aaac68580806e9aa7b136d284bec206
https://doi.org/10.1002/ajh.23994
https://doi.org/10.1002/ajh.23994
Autor:
Federico Fallanca, A. Fijołek-Warszewska, M. Dziuk, Renata Zaucha, Krzysztof Leśniewski-Kmak, Dariusz Woszczyk, Dariusz Świetlik, Joanna Tajer, Waldemar Kulikowski, Wanda Knopinska-Posluszny, R. Kroll-Balcerzak, Tomasz Wróbel, Jan Walewski, Edyta Subocz, Jan Maciej Zaucha, Stephane Chauvie, Agnieszka Giza, A. Gallamini, Pawel Kurczab, Fabrizio Bergesio, Bogdan Małkowski, M. Kobylecka, A. Romanowicz, Alberto Biggi, A. Chamier-Ciemińska, Justyna Rybka
Background Interim PET after two ABVD cycles (iPET2) predicts treatment outcome in classical Hodgkin’s lymphoma. To test whether an earlier assessment of chemosensitivity would improve the prediction accuracy, we launched a prospective, multicenter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2672cf0469d2c7ef733c2eae0b59868
https://ruj.uj.edu.pl/xmlui/handle/item/141375
https://ruj.uj.edu.pl/xmlui/handle/item/141375
Publikováno v:
Physica Medica. 56:260
Purpose The aim of this work was to compare the results obtained by the procedure for qualifying PET/CT scanners for Clinical Trial Qualification (CTQ) adopted by the Italian Foundation on Lymphoma (FIL), the Grupo Espanol de Linfomas/Transplante Aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92e14261b0ee389165d2ffa13aeb16aa
https://doi.org/10.1016/j.ejmp.2018.04.335
https://doi.org/10.1016/j.ejmp.2018.04.335